Respiratory eHealth company Adherium (ASX:ADR) has announced a £499,871 (approximately $880,000) award for a pathfinder service development project from the UK National Health Service’s Small Business Research Initiative Healthcare (SBRI Healthcare).
The project is titled 'Smart Digital inhaler enabled asthma management in high-risk children aged 5 to 16 years managed in primary care to prevent asthma attacks'.
This project will use Adherium's Hailie digital inhalers that alert the child and display usage on the family’s smartphone. The medical team can monitor and support families and their child’s medication online, with the aim of reducing asthma attacks.
“This is a unique opportunity and privilege to reach high-risk children early and potentially save them and their families from the repeated challenge of exacerbations. These cause distress and can lead to emergency department visits and hospitalisation,” said Francis White, Adherium’s vice president of global business development.
Adherium’s partner, Helicon Health, will work with the research team led by Dr Erol Gaillard at the University of Leicester to identify patients in primary care and offer them the Hailie system.
The project is also backed by the Leicester Integrated Care Board, East Midlands AHSN.